T-cell dependent immunoselection

Affiliations

Comment

Mads Hald Andersen. Oncoimmunology. 2012.

. 2012 Oct 1;1(7):1003.

doi: 10.4161/onci.20927.

¹ Department of Hematology; Center for Cancer Immune Therapy (CCIT); Copenhagen University Hospital Herlev; Herlev, Denmark.

No abstract available

Comment on

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD. Matsushita H, et al. Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755. Nature. 2012. PMID: 22318521 Free PMC article.

1. Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature. 2012;482:400–4. doi: 10.1038/nature10755. - DOI - PMC - PubMed
1. DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature. 2012;482:405–9. doi: 10.1038/nature10803. - DOI - PMC - PubMed
1. Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, et al. Immunogenicity of constitutively active V599EBRaf. Cancer Res. 2004;64:5456–60. doi: 10.1158/0008-5472.CAN-04-0937. - DOI - PubMed
1. Sharkey MS, Lizée G, Gonzales MI, Patel S, Topalian SL. CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation. Cancer Res. 2004;64:1595–9. doi: 10.1158/0008-5472.CAN-03-3231. - DOI - PubMed
1. Kubuschok B, Neumann F, Breit R, Sester M, Schormann C, Wagner C, et al. Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer. Clin Cancer Res. 2006;12:1365–72. doi: 10.1158/1078-0432.CCR-05-1672. - DOI - PubMed